To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.

1/11/2023, 1:31 PM

Congressional Summary of HR 2452

This bill amends the Federal Food, Drug, and Cosmetic Act to revise the requirements for health care economic information that is provided to entities selecting drugs for coverage or reimbursement, such as formularies. The information must include a conspicuous and prominent statement describing the differences between the information and the labeling approved for the drug.

"Health care economic information" is an analysis that describes the economic consequences of the use of a drug. Such an analysis is no longer required to compare the use of the drug to another intervention or no intervention. An analysis that relates only to an indication for which the drug is not approved is not health care economic information.

Current Status of Bill HR 2452

Bill HR 2452 is currently in the status of Bill Introduced since May 19, 2015. Bill HR 2452 was introduced during Congress 114 and was introduced to the House on May 19, 2015.  Bill HR 2452's most recent activity was Referred to the Subcommittee on Health. as of May 22, 2015

Bipartisan Support of Bill HR 2452

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
1
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 2452

Primary Policy Focus

Health

Potential Impact Areas

Drug safety, medical device, and laboratory regulationHealth information and medical records

Alternate Title(s) of Bill HR 2452

To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.
Start holding our government accountable!

Comments